Category:
Protein/Antigen/Polypeptide
CAS NO:
/
Standard:
ChP,
Name:
Human Hepatitis B Immunoglobulin (pH4) for Intravenous Injection
Use within:
36 months
Specifications:
Each vial contains 2000IU (40ml) anti-HBs.
Approval Number:
SFDA Approval No. S20083007
Indications:
Combination with lamivudine for the prevention of hepatitis B virus (HBV) re-infection in liver transplant patients.